Article Information
History
- August 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Division of Population, Health and Genomics, Ninewells Hospital and Medical School, University of Dundee, United Kingdom
- 2Institute of Neuroscience, National Research Council, University of Padua, Italy
- ↵*Corresponding Author Professor Ewan Pearson, Professor of Diabetic Medicine, Head of Division, Division of Population, Health, and Genomics, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Email: e.z.pearson{at}dundee.ac.uk, Telephone: +44 1382 383 387
Posted August 24, 2023.
Combination low dose sulphonylurea and DPP4 inhibitor have potent glucose lowering effect through augmentation of beta cell function without increase in hypoglycaemia: a randomised crossover study
